Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes. [electronic resource] by
- Watson, A M D
- Olukman, M
- Koulis, C
- Tu, Y
- Samijono, D
- Yuen, D
- Lee, C
- Behm, D J
- Cooper, M E
- Jandeleit-Dahm, K A M
- Calkin, A C
- Allen, T J
Producer: 20131029
In:
Diabetologia vol. 56
Availability: No items available.
|
|
|
9.
|
Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes. [electronic resource] by
- Koïtka, A
- Cao, Z
- Koh, P
- Watson, A M D
- Sourris, K C
- Loufrani, L
- Soro-Paavonen, A
- Walther, T
- Woollard, K J
- Jandeleit-Dahm, K A M
- Cooper, M E
- Allen, T J
Producer: 20101022
In:
Diabetologia vol. 53
Availability: No items available.
|
|
|
10.
|
Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice. [electronic resource] by
- Watson, A M D
- Soro-Paavonen, A
- Sheehy, K
- Li, J
- Calkin, A C
- Koitka, A
- Rajan, S N
- Brasacchio, D
- Allen, T J
- Cooper, M E
- Thomas, M C
- Jandeleit-Dahm, K J A
Producer: 20110525
In:
Diabetologia vol. 54
Availability: No items available.
|